文献リスト

1) Sultana S, Awai K, Nakayama Y, et al. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging. Radiology. 2007; 243: 140-7

2) Yanaga Y, Awai K, Nakaura T, et al. Optimal contrast dose for depiction of hypervascular hepatocellular carcinoma at dynamic CT using 64-MDCT. AJR Am J Roentgenol. 2008; 190: 1003-9

3) Okada M, Murakami T, Kumano S, et al. Comparison between one-route and two-route injection for liver and aortic enhancement using MDCT. AJR Am J Roentgenol. 2008; 190: W323-6

4) Ho LM, Nelson RC, Delong DM. Determining contrast medium dose and rate on basis of lean body weight: does this strategy improve patient-to-patient uniformity of hepatic enhancement during multi-detector row CT？ Radiology. 2007; 243: 431-7

5) Uppot RN, Sahani DV, Hahn PF, et al. Impact of obesity on medical imaging and image-guided intervention. AJR Am J Roentgenol. 2007; 188: 433-40

6) Maetani YS, Isoda H, Nomura A, et al. CT laparoscopy for detecting small superficial metastatic lesions of the liver surface: initial experience. AJR Am J Roentgenol. 2008; 190: 1314-7

7) Hashimoto K, Murakami T, Dono K, et al. Quantitative tissue blood flow measurement of the liver parenchyma: comparison between xenon CT and perfusion CT. Dig Dis Sci. 2007; 52: 943-9

8) Shinmura R, Matsui O, Kadoya M, et al. Detection of hypervascular malignant foci in borderline lesions of hepatocellular carcinoma: comparison of dynamic multi-detector row CT, dynamic MR imaging and superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol. 2008; 18: 1918-24

9) Nishie A, Yoshimitsu K, Irie H, et al. Radiological detectability of minute hepatic venous invasion in hepatocellular carcinoma. Eur J Radiol. 2008. Epub ahead of print

10) Montet X, Pastor CM, Vallee JP, et al. Improved visualization of vessels and hepatic tumors by micro-computed tomography (CT) using iodinated liposomes. Invest Radiol. 2007; 42: 652-8

11) Zheng J, Perkins G, Kirilova A, et al. Multimodal contrast agent for combined computed tomography and magnetic resonance imaging applications. Invest Radiol. 2006; 41: 339-48

12) Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol. 2008; 18: 457-67

13) Saito K, Kotake F, Ito N, et al. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci. 2005; 4: 1-9

14) Dahlstrom N, Persson A, Albiin N, et al. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects. Acta Radiol. 2007; 48: 362-8

15) Tschirch FT, Struwe A, Petrowsky H, et al. Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol. 2008; 18: 1577-86

16) Reimer P, Schneider G, Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol. 2004; 14: 559-78

17) Kanematsu M, Goshima S, Kondo H, et al. Gadolinium-enhanced multiphasic 3D MRI of the liver with prospective adaptive navigator correction: phantom study and preliminary clinical evaluation. AJR Am J Roentgenol. 2007; 188: W309-16

18) Merkle EM, Dale BM. Abdominal MRI at 3. 0 T: the basics revisited. AJR Am J Roentgenol. 2006; 186: 1524-32

19) von Falkenhausen MM, Lutterbey G, Morakkabati-Spitz N, et al. High-field-strength MR imaging of the liver at 3. 0 T: intraindividual comparative study with MR imaging at 1. 5 T. Radiology. 2006; 241: 156-66

20) Kim YK, Kim CS, Chung GH, et al. Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma. AJR Am J Roentgenol. 2006; 186: 149-57

21) Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology. 2008; 246: 812-22

22) Venkatesh SK, Yin M, Glockner JF, et al. MR elastography of liver tumors: preliminary results. AJR Am J Roentgenol. 2008; 190: 1534-40

23) Huwart L, Sempoux C, Salameh N, et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology. 2007; 245: 458-66

24) Tsuda N, Okada M, Murakami T. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging. Invest Radiol. 2007; 42: 242-7

25) O'Regan DP, Callaghan MF, Wylezinska-Arridge M, et al. Liver fat content and T2＊: simultaneous measurement by using breath-hold multiecho MR imaging at 3. 0 T−feasibility. Radiology. 2008; 247: 550-7

26) Yanagisawa K, Moriyasu F, Miyahara T, et al. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol. 2007; 33: 318-25

27) Watanabe R, Matsumura M, Munemasa T, et al. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol. 2007; 42: 643-51

28) Numata K, Morimoto M, Ogura T, et al. Ablation therapy guided by contrast-enhanced sonography with sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J Ultrasound Med. 2008; 27: 395-406

29) Kudo M. New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma. Hepatol Res. 2007; 37 Suppl 2: S193-9

30) Minami Y, Chung H, Kudo M, et al. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation. AJR Am J Roentgenol. 2008; 190: W335-41

31) Kitada T, Murakami T, Kuzushita N, et al. Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas. Hepatol Res. 2008; 38: 565-71

32) Nicolau C, Vilana R, Bianchi L, et al. Early-stage hepatocellular carcinoma: the high accuracy of real-time contrast-enhanced ultrasonography in the assessment of response to percutaneous treatment. Eur Radiol. 2007; 17 Suppl 6: F80-8

33) Kudo K, Moriyasu F, Mine Y, et al. Preoperative RFA simulation for liver cancer using a CT virtual ultrasound system. Eur J Radiol. 2007; 61: 324-31

34) Iijima H, Moriyasu F, Tsuchiya K, et al. Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis. Hepatol Res. 2007; 37: 722-30

35) Filippone A, Iezzi R, Di Fabio F, et al. Multidetector-row computed tomography of focal liver lesions treated by radiofrequency ablation: spectrum of findings at long-term follow-up. J Comput Assist Tomogr. 2007; 31: 42-52

36) Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol. 2007; 188: 480-8

37) Wen YL, Kudo M, Zheng RQ, et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol. 2003; 181: 57-63

38) Bartolotta TV, Taibbi A, Midiri M, et al. Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound. Abdom Imaging. 2008; 33: 501-11

39) Khankan AA, Murakami T, Onishi H, et al. Hepatocellular carcinoma treated with radio frequency ablation: An early evaluation with magnetic resonance imaging. J Magn Reson Imaging. 2008; 27: 546-51

40) Bathe OF, Mahallati H. MR-guided ablation of hepatocellular carcinoma aided by gadoxetic acid. J Surg Oncol. 2007; 95: 670-3

41) Travaini LL, Trifiro G, Ravasi L, et al. Role of [(18)F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results. Eur J Nucl Med Mol Imaging. 2008; 35: 1316-22

42) Head HW, Dodd GD 3rd, Dalrymple NC, et al. Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: frequency of diaphragmatic injury. Radiology. 2007; 243: 877-84

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp